Thursday, July 3, 2025

Datametrex Announces Binding Letter Of Intent To Acquire Concierge Medical Telehealth Platform

Datametrex AI (TSXV: DM) this morning has announced that it has entered into a binding letter of intent for the acquisition of Concierge Medical Consultant. Concierge is described as being a private telehealth and medical concierge services company, which is in line with yesterdays announcement of a concierge COVID-19 testing program that company implemented for travelers.

Datametrex AI's Logo

Concierge was founded in 2018 as a telehealth and urgent medical care platform, with the principal thesis being that urgent care does not just happen in the doctors office or an emergency room. The firm is reportedly currently generating revenue through a subscription model that is offered directly to consumers in both the home and workplace setting.

Given the current pandemic environment, Datametrex has identified that there is a high probability in regards to an increase of mental health issues in society as a result of prolonged isolation and lack of social interaction. Thus, there is a need for telehealth and personal health solutions such as concierge medical solutions. Further, its experience in working with artificial intelligence will be utilized to enhance the platform while the firm will working to push it into other jurisdictions.

“We strongly believe that there is a growing need for remote health and wellness solutions as a result of the pandemic. The lockdowns and the isolation that Canadians have endured this past year have only increased the need for mental and physical health solutions.”

Andrew Ryu, Chairman of Datametrex

The proposed transaction is to consist of an all share purchase of Concierge Medical, at a purchase price of $750,000. Shares issued under the transaction are to be based on the closing price of the equity three days prior to the closing of the transaction. Closing of the arrangement is subject to the execution of a definitive agreement, the approval of directors of Datametrex, and the approval of the shareholders of Concierge.

Datametrex AI last traded at $0.19 on the TSX Venture.


FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Datametrex Provides Clarity Regarding Air Canada Twitter Comments

Datametrex AI (TSXV: DM) this morning looked to clear up some questions being posed by...

Friday, December 11, 2020, 08:12:28 AM

Datametrex Secures Exclusive Rights For COVID-19 Saliva Test Kit In Canada, Saudi Arabia

Datametrex AI (TSXV: DM) has secured further test kits for its COVID-19 testing operation. The...

Wednesday, February 3, 2021, 08:05:27 AM

Datametrex Secures Another $450,000 COVID-19 Test Kit Purchase Order

The checks just keep on coming in for Datametrex AI (TSXV: DM). The company announced...

Monday, June 8, 2020, 10:31:48 AM

Datametrex Signs Sales Agreement With 7-Eleven Korea

Datametrex AI (TSXV: DM) this morning had another major news release, announcing that the firm...

Thursday, September 10, 2020, 10:05:22 AM

Market Movers: Datametrex Catches the COVID Tradewinds

2017 feels like it happened on another planet, and those of us who were there...

Thursday, April 23, 2020, 03:10:57 AM